US SB1437 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 13 2019 - 25% progression, died in committee
Action: 2019-05-13 - Read twice and referred to the Committee on Finance. (text: CR S2791)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 13 2019 - 25% progression, died in committee
Action: 2019-05-13 - Read twice and referred to the Committee on Finance. (text: CR S2791)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.
Title
Drug-price Transparency in Communications (DTC) Act
Sponsors
| Sen. Richard Durbin [D-IL] | Sen. Chuck Grassley [R-IA] | Sen. Angus King [I-ME] | Sen. Lamar Alexander [R-TN] |
| Sen. Joni Ernst [R-IA] | Sen. Tammy Baldwin [D-WI] | Sen. Tina Smith [D-MN] | Sen. Rick Scott [R-FL] |
| Sen. Richard Blumenthal [D-CT] | Sen. Mike Braun [R-IN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-05-13 | Senate | Read twice and referred to the Committee on Finance. (text: CR S2791) |
Subjects
Consumer affairs
Health
Health care costs and insurance
Inflation and prices
Marketing and advertising
Medicaid
Medicare
Prescription drugs
Health
Health care costs and insurance
Inflation and prices
Marketing and advertising
Medicaid
Medicare
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1437/all-info |
| Text | https://www.congress.gov/116/bills/s1437/BILLS-116s1437is.pdf |
